Qingdao Central Hospital
Qingdao Central Hospital
Qingdao, China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not stated | 2026-01-12 | NCT06210776 | |
| Osimertinib Combined With Savolitinib in the Treatment of NSCLC With Low Copy Number MET Amplification | EGFR Positive Non-small Cell Lung Cancer; MET Amplification | Recruiting | Phase 2 | 2026-01-07 | NCT07322783 | |
| Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer | EFS; pCR Rate | Active, not recruiting | Phase 2 | 2025-07-29 | NCT07090031 |